Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Hepatitis Therapeutics Market Size study, by Disease Type (Hepatitis A, B, C and Others) and Regional Forecasts 2021-2027

  • BIZ4599852
  • 200 Pages
  • July 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Hepatitis Therapeutics Market is valued approximately USD 21.5 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 2.3% over the forecast period 2021-2027. Hepatitis is a disease which causes inflammation of the liver which causes a range of health problems and can lead to death. There are generally five main strains of the hepatitis virus, which are referred as types A, B, C, D and E. The growing incidences of viral hepatitis across globe, rise in the number of autoimmune diseases, coupled with increased healthcare expenditures worldwide, are driving the Hepatitis Therapeutics market. The number of death caused by hepatitis is more than the deaths caused by HIV and TB, and hence the eradication of diseases is of prime importance. According to World Health Organization in 2019, approximately 325 million people suffer from hepatitis B and/or C worldwide. Globally, an estimated 71 million people have chronic hepatitis C virus infection. WHO’s global hepatitis strategy aims to reduce new hepatitis infections by significant 90% and deaths by 65% between 2016 and 2030. This strategy is endorsed by all WHO members. It also states that 4.5 million premature deaths can be prevented in low and middle-income countries by 2030 through vaccination, diagnostic tests and medicines. Antiviral medicines can treat nearly 95% of patients with hepatitis C infection, thereby reducing the risk of death from cirrhosis and liver cancer. The lack of treatment facilities available in low-income nations and poor healthcare accessibility may act as a restraint for hepatitis therapeutics market growth. However, increasing efforts from government as well as international organizations in the form of funds, regulations and strategies act as an opportunity for Hepatitis Therapeutics Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Hepatitis Therapeutics Market. Due to higher investment in therapeutic treatment as well as higher per capita income, North America has emerged as a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit the highest growth rate for the forecast period 2021-2027 owing to the growing hepatitis prevalence in underdeveloped areas of the region. Rising disposable income and growing GDPs of many countries will also boost growth in this region.

Major market player included in this report are:

Gilead Lifesciences

Bristol-Myers Squibb Co

Biocon

AbbVie

Merck & Co., Inc.,

Johnson & Johnson

Roche

Novartis

Sanofi

Cipla

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Type:

Hepatitis A

Hepatitis B

Hepatitis C

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Hepatitis Therapeutics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Hepatitis Therapeutics Market, by Disease Type, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Hepatitis Therapeutics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Hepatitis Therapeutics Market Dynamics

3.1. Hepatitis Therapeutics Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Increasing incidences of hepatitis across world

3.1.1.2. Rising expenditure in healthcare sector

3.1.2. Market Challenges

3.1.2.1. Lack of medical facilities in low-income countries

3.1.3. Market Opportunities

3.1.3.1. Increasing governmental and global efforts to curb hepatitis

Chapter 4. Global Hepatitis Therapeutics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Hepatitis Therapeutics Market, by Disease Type

5.1. Market Snapshot

5.2. Global Hepatitis Therapeutics Market by Disease Type, Performance - Potential Analysis

5.3. Global Hepatitis Therapeutics Market Estimates & Forecasts by Disease Type 2018-2027 (USD Billion)

5.4. Hepatitis Therapeutics Market, Sub Segment Analysis

5.4.1. Hepatitis A

5.4.2. Hepatitis B

5.4.3. Hepatitis C

5.4.4. Others

Chapter 6. Global Hepatitis Therapeutics Market, Regional Analysis

6.1. Hepatitis Therapeutics Market, Regional Market Snapshot

6.2. North America Hepatitis Therapeutics Market

6.2.1. U.S. Hepatitis Therapeutics Market

6.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2027

6.2.2. Canada Hepatitis Therapeutics Market

6.3. Europe Hepatitis Therapeutics Market Snapshot

6.3.1. U.K. Hepatitis Therapeutics Market

6.3.2. Germany Hepatitis Therapeutics Market

6.3.3. France Hepatitis Therapeutics Market

6.3.4. Spain Hepatitis Therapeutics Market

6.3.5. Italy Hepatitis Therapeutics Market

6.3.6. Rest of Europe Hepatitis Therapeutics Market

6.4. Asia-Pacific Hepatitis Therapeutics Market Snapshot

6.4.1. China Hepatitis Therapeutics Market

6.4.2. India Hepatitis Therapeutics Market

6.4.3. Japan Hepatitis Therapeutics Market

6.4.4. Australia Hepatitis Therapeutics Market

6.4.5. South Korea Hepatitis Therapeutics Market

6.4.6. Rest of Asia Pacific Hepatitis Therapeutics Market

6.5. Latin America Hepatitis Therapeutics Market Snapshot

6.5.1. Brazil Hepatitis Therapeutics Market

6.5.2. Mexico Hepatitis Therapeutics Market

6.6. Rest of The World Hepatitis Therapeutics Market

Chapter 7. Competitive Intelligence

7.1. Top Market Strategies

7.2. Company Profiles

7.3. Gilead Lifesciences

7.3.1.1. Key Information

7.3.1.2. Overview

7.3.1.3. Financial (Subject to Data Availability)

7.3.1.4. Product Summary

7.3.1.5. Recent Developments

7.3.2. Bristol-Myers Squibb Co

7.3.3. Biocon

7.3.4. AbbVie

7.3.5. Merck & Co., Inc.,

7.3.6. Johnson & Johnson

7.3.7. Roche

7.3.8. Novartis

7.3.9. Sanofi

7.3.10. Cipla

Chapter 8. Research Process

8.1. Research Process

8.1.1. Data Mining

8.1.2. Analysis

8.1.3. Market Estimation

8.1.4. Validation

8.1.5. Publishing

8.2. Research Attributes

8.3. Research Assumption

List of Tables

TABLE 1. Global Hepatitis Therapeutics Market, report scope

TABLE 2. Global Hepatitis Therapeutics Market estimates & forecasts by region 2018-2027 (USD Billion)

TABLE 3. Global Hepatitis Therapeutics Market estimates & forecasts by Disease Type 2018-2027 (USD Billion)

TABLE 4. Global Hepatitis Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 5. Global Hepatitis Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Hepatitis Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Hepatitis Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Hepatitis Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Hepatitis Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Hepatitis Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Hepatitis Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Hepatitis Therapeutics Market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Hepatitis Therapeutics Market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. U.S. Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. U.S. Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 16. U.S. Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 17. Canada Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 18. Canada Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 19. Canada Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. UK Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 21. UK Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 22. UK Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. Germany Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 24. Germany Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 25. Germany Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. RoE Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 27. RoE Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 28. RoE Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. China Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 30. China Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 31. China Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. India Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 33. India Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 34. India Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. Japan Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 36. Japan Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 37. Japan Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. RoAPAC Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 39. RoAPAC Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 40. RoAPAC Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. Brazil Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 42. Brazil Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 43. Brazil Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. Mexico Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 45. Mexico Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 46. Mexico Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. RoLA Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 48. RoLA Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 49. RoLA Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. Row Hepatitis Therapeutics Market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 51. Row Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 52. Row Hepatitis Therapeutics Market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. List of secondary sources, used in the study of global Hepatitis Therapeutics Market

TABLE 54. List of primary sources, used in the study of global Hepatitis Therapeutics Market

TABLE 55. Years considered for the study

TABLE 56. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
View Details
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
View Details
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390
View Details
 
View More
 

Client Testimonials

2025 © Copyright Big Market Research